J Bone Miner Res. 2024 Jul 20. pii: zjae105. [Epub ahead of print]
Katsuhiko Kamei,
Yasuhito Yahara,
Jun-Dal Kim,
Mamiko Tsuji,
D Mami Iwasaki,
Hiroshi Takemori,
Shoji Seki,
Hiroto Makino,
Hayato Futakawa,
Tatsuro Hirokawa,
Tran Canh Tung Nguyen,
Takashi Nakagawa,
Yoshiharu Kawaguchi.
Maintenance of bone homeostasis and the balance between bone resorption and formation are crucial for maintaining skeletal integrity. This study sought to investigate the role of salt-inducible kinase 3 (SIK3), a key regulator in cellular energy metabolism, during the differentiation of osteoclasts. Despite osteoclasts being high energy-consuming cells essential for breaking down mineralized bone tissue, the specific function of SIK3 in this process remains unclear. To address this issue, we generated osteoclast-specific SIK3 conditional knockout mice and assessed the impact of SIK3 deletion on bone homeostasis. Our findings revealed that SIK3 conditional knockout mice exhibited increased bone mass and an osteopetrosis phenotype, suggesting a pivotal role for SIK3 in bone resorption. Moreover, we assessed the impact of pterosin B, a SIK3 inhibitor, on osteoclast differentiation. The treatment with pterosin B inhibited osteoclast differentiation, reduced the numbers of multinucleated osteoclasts, and suppressed resorption activity in vitro. Gene expression analysis demonstrated that SIK3 deletion and pterosin B treatment influence a common set of genes involved in osteoclast differentiation and bone resorption. Furthermore, pterosin B treatment altered intracellular metabolism, particularly affecting key metabolic pathways, such as the tricarboxylic acid cycle and oxidative phosphorylation. These results provide valuable insights into the involvement of SIK3 in osteoclast differentiation and the molecular mechanisms underlying osteoclast function and bone diseases.
Keywords: Osteoclasts; Salt-inducible kinase 3; mitochondria; mitochondrial respiration; oxidative phosphorylation